2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Dermatomyositis, Adult Type: new trials by email Literature Review of Dermatomyositis, Adult Type trials Research Report on Dermatomyositis, Adult Type
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predominant Dermatomyositis Brepocitinib - Dermatomyositis, Dermatomyositis, Adult Type | Phase 2 | Completed | Priovant Therapeutics, Inc. | 5 | 2024-08-28 | 2025-05-20 |
| Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant Dermatomyositis Apremilast 30mg - Dermatomyositis, Adult Type | Phase 2 | Completed | Tulane University | 8 | 2018-06-12 | 2023-03-03 |
Dermatomyositis (2)
Connective Tissue Diseases (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Myositis (2) · Nervous System Diseases (2) · Neuromuscular Diseases (2) · Polymyositis (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2)
apremilast (1)
Priovant Therapeutics, Inc. (1) · Tulane University (1)
United States (2)
Carole Bitar, MD (1)